Abstract:Motivation: Computational drug repositioning is an important and efficient approach towards identifying novel treatments for diseases in drug discovery. The emergence of large-scale, heterogeneous biological and biomedical datasets has provided an unprecedented opportunity for developing computational drug repositioning methods. The drug repositioning problem can be modeled as a recommendation system that recommends novel treatments based on known drug-disease associations. The formulation under this recommendation system is matrix completion, assuming that the hidden factors contributing to drug-disease associations are highly correlated and thus the corresponding data matrix is low-rank. Under this assumption, the matrix completion algorithm fills out the unknown entries in the drug-disease matrix by constructing a low-rank matrix approximation, where new drug-disease associations having not been validated can be screened.Results: In this work, we propose a drug repositioning recommendation system (DRRS) to predict novel drug indications by integrating related data sources and validated information of drugs and diseases. Firstly, we construct a heterogeneous drug-disease interaction network by integrating drug-drug, disease-disease and drug-disease networks. The heterogeneous network is represented by a large drug-disease adjacency matrix, whose entries include drug pairs, disease pairs, known drug-disease interaction pairs and unknown drug-disease pairs. Then, we adopt a fast Singular Value Thresholding (SVT) algorithm to complete the drug-disease adjacency matrix with predicted scores for unknown drug-disease pairs. The comprehensive experimental results show that DRRS improves the prediction accuracy compared with the other state-of-the-art approaches. In addition, case studies for several selected drugs further demonstrate the practical usefulness of the proposed method.Availability and implementation: http://bioinformatics.csu.edu.cn/resources/softs/DrugRepositioning/DRRS/index.html.Contact: yaohang@cs.odu.edu or jxwang@mail.csu.edu.cn.Supplementary information: Supplementary data are available at Bioinformatics online.

A Review of Drug Repositioning Based Chemical-induced Cell Line Expression Data

A Review of Current In Silico Methods for Repositioning Drugs and Chemical Compounds

A Pathway Profile-Based Method for Drug Repositioning

Prediction of drug-target interactions for drug repositioning only based on genomic expression similarity

Drugsig: A Resource For Computational Drug Repositioning Utilizing Gene Expression Signatures

An Analytical Review of Computational Drug Repurposing

Gene Signature-Based Drug Repositioning

A Computational Strategy for Drug Repositioning Based on Support-Vector Regression Algorithm

A Study on Methodologies of Drug Repositioning Using Biomedical Big Data: A Focus on Diabetes Mellitus

In silico drug repositioning based on drug-miRNA associations

DrugRepPT: a Deep Pre-Training and Fine-Tuning Framework for Drug Repositioning Based on Drug's Expression Perturbation and Treatment Effectiveness.

Computational Drug Repositioning with Random Walk on a Heterogeneous Network

Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm

A comparative benchmarking and evaluation framework for heterogeneous network-based drug repositioning methods

A drug repurposing method based on inhibition effect on gene regulatory network

DrugReSC: targeting disease-critical cell subpopulations with single-cell transcriptomic data for drug repurposing in cancer

DrugRepoBank: a comprehensive database and discovery platform for accelerating drug repositioning

Computational drug repositioning using low-rank matrix approximation and randomized algorithms

Repositioning Drugs For Breast Cancer Based On The Identification Of Cancer Related Signaling Pathways

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

Turning genome-wide association study findings into opportunities for drug repositioning